Skip to content

Tinaquant 2Microglobulin 11660551216Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04015630900152), received between Apr 25, 2019 and Apr 25, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Low Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Low Test Results1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 25, 2019Low Test Results; Low Test Results

    THIS REPORT SUMMARIZES <NOE>1</NOE> MALFUNCTION EVENTS. ERRONEOUS LOW RESULTS WERE GENERATED BY A COBAS 6000 C (501) MODULE. THE EVENTS INVOLVED 1 PATIENT WITH DISCREPANT RESULTS FOR B2MG TINA-QUANT BETA2-MICROGLOBULIN. THE PROVIDED PATIENT'S AGE WAS (B)(6). THE PATIENT WAS A FEMALE.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8551517 ↗

Other SYSTEM, TEST, BETA-2-MICROGLOBULIN IMMUNOLOGICAL devices

All SYSTEM, TEST, BETA-2-MICROGLOBULIN IMMUNOLOGICAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page